Psychosocial Treatments

Although this chapter has presented only pharmacotherapies for opioid addiction, it is crucial that psychosocial interventions be used to help these patients change their lifestyles. It is generally accepted that escape from drug seeking and the accompanying antisocial impulses requires a change in deeply rooted behavioral patterns. Individual and group psychotherapy may be useful in approaching this goal. Contingency management may be very helpful (Robles, Stitzer, Strain, Bigelow, & Silverman, 2002). The various 12-step programs such as Narcotics Anonymous are also useful adjuncts to treatment and facilitate significant degrees of change. For those persons who continue to relapse in less restrictive treatment settings, a "therapeutic community" may be the appropriate next step (O'Brien & Biase, 1981); these nonhospital, community-based, 24-hour, live-in programs are geared to subject the addict to continuous treatment pressure for as long as 1 or 2 years. Personal freedom is severely curtailed, and community rules are rigorously enforced. The goal is to use nonviolent but highly confrontational tactics, in the context of peer pressure, for the purpose of breaking down denial and exposing destructive attitudes and behaviors that formerly led to drug use (Rosenthal, 1989). A growth process may then occur, allowing the individual to achieve a degree of personal integrity that is unrelated to the former identity of drug abuser. When successful, this type of personal transformation can lead to permanent recovery. However, this form of treatment requires total commitment, which many opioid addicts are unable to make; thus, the dropout rate is high. As with any treatment modality, selection of appropriate candidates leads to greater success.


American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author. Berger, P. A., & Dunn, M. J. (1986). The biology and treatment of drug abuse. In S. Arieti (Ed.), American handbook of psychiatry (Vol. 8, pp. 811-822). New York: Basic Books.

Bickel, W. K., Stitzer, M. L., Bigelow, G. E., Liebson, I. A., Jasinski, D. R., & Johnson, R. E. (1988). A clinical trial of buprenorphine: Comparison with methadone in the detoxification of heroin addicts. Clin Pharmacol Ther, 43, 72-78.

Brewer, C., Rezae, H., & Bailey, C. (1988). Opioid withdrawal and naltrexone induction in 48-72 hours with minimal drop-out, using a modification of the naltrexone-clonidine technique. Br J Psychiatry, 153, 340-343.

Brooner, R. K., King, V. L., Kidorf, M., Schmidt, C. W. Jr., & Bigelow, G. E. (1997). Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry, 54, 71-80.

Charney, D. S., Heninger, G. R., & Kleber, H. D. (1986). The combined use of clonidine and naltrexone as a rapid, safe, and effective treatment of abrupt withdrawal from methadone. Am J Psychiatry, 143, 831-837.

Cheskin, L. J., Fudala, P. J., & Johnson, R. E. (1994). A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids. Drug Alcohol Depend, 36, 115-121.

Deneau, G. A., & Mule, S. J. (1981). Pharmacology of the opiates. In J. H. Lowinson & P. Ruiz (Eds.), Substance abuse: Clinical problems and perspectives (pp. 129-139). Baltimore: Williams & Wilkins.

Finnegan, L. P. (Ed.). (1979). Drug dependency in pregnancy: Clinical management of mother and child. Rockville, MD: National Institute on Drug Abuse.

Gerra, G., Marcato, A., Caccavari, R., Fontanesi, B., Deisignore, R., Fertonani, G., et al. (1995). Clonidine and opiate receptor antagonists in the treatment of heroin addiction. J Subst Abuse Treat, 12, 35-41.

Gerstein, D. R. (1990). The effectiveness of treatment. In D. R. Gerstein & H. J. Har-wood (Eds.), Treating drug problems (Vol. 1, pp. 132-199). Washington, DC: National Academy Press.

Gold, M. S., Pottash, A. C., Sweeney, D. R., & Kleber, H. D. (1980). Opiate withdrawal using clonidine. JAMA, 243(4), 343-346.

Hensel, M., & Kox, W. J. (2000). Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anesthesia: A prospective study in methadone, heroin, codeine, and morphine addicts. Acta Anaesthsiol Scand, 44(3), 326-333.

Jaffe, J. H. (1989). Psychoactive substance use disorders. In H. I. Kaplan & B. J. Sadock (Eds.), Comprehensive textbook of psychiatry (5th ed., pp. 642-698). Baltimore: Williams & Wilkins.

Jasinski, D. R., Johnson, R. E., & Kocher, T. R. (1985). Clonidine in morphine withdrawal: Differential effects on signs and symptoms. Arch Gen Psychiatry, 42, 10631066.

Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000). A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N Engl J Med, 343, 1290-1297.

Johnson, R. E., & Strain, E. C. (1999). Other medications for opioid dependence. In E. C. Strain & M. L. Stitzer (Eds.), Methadone treatment for opioid dependence (pp. 281-321). Baltimore: Johns Hopkins University Press.

Khantzian, E. J., & Treece, C. (1985). DSM-III psychiatric diagnosis of narcotic addicts: Recent findings. Arch Gen Psychiatry, 42, 1067-1071.

King, V. L., Brooner, R. K., Kidorf, M. S., Stoller, K. B., & Mirsky, A. F. (1999). Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment. J Nerv Ment Dis, 187(8), 487-495.

Kleber, H. D., Riordan, C. E., Rounsaville, B., Kosten, T., Charney, D., Gaspari, J., et al. (1985). Clonidine in outpatient detoxification from methadone maintenance. Arch Gen Psychiatry, 42, 391-394.

Koob, G. F., & Bloom, F. E. (1988). Cellular and molecular mechanisms of drug dependence. Science, 242, 715-723.

Martin, W. R., & Jasinski, D. R. (1969). Physiological parameters of morphine dependence in men: Tolerance, early abstinence, protracted abstinence. J Psychiatr Res, 7, 9-17.

Mattick, R. P., Ali, R., White, J. M., O'Brien, S., Wolk, S., & Danz, C. (2003). Buprenorphine versus methadone maintenance therapy: A randomized double blind trial with 405 opioid-dependent patients. Addiction, 98, 441-452.

Mirin, S. M., Weiss, R. D., Michael, J., & Griffin, M. L. (1989). Psychopathology in substance abusers: Diagnosis and treatment. Am J Drug Alcohol Abuse, 14, 139157.

O'Brein, W. B., & Biase, D. V. (1981). The therapeutic community: The family-milieu approach to recovery. In J. H. Lowinson & P. Ruiz (Eds.), Substance abuse: Clinical problems and perspectives (pp. 303-316). Baltimore: Williams & Wilkins.

O'Connor, P. G., Waugh, M. E., Carroll, K. M., Rounsaville, B. J., Diagkogiannis, I. A., & Schottenfeld, R. S. (1995). Primary care-based ambulatory opioid detoxification: The results of a clinical trial. J Gen Intern Med, 10, 255-260.

Otto, K. C. (2003). Acupuncture and substance abuse: A synopsis, with indications for further research. Am J Addict, 12(1), 43-51.

Petitjean, S., Stohler, R., Deglon, J. J., Livoti, S., Waldvogel, D., Uehlinger, C., & Ladenwig, D. (2001). Double-blind randomized trial of buprenorphine and methadone in opiate dependence. Drug Alcohol Depend, 62, 97-104.

Rabinowitz, J., Cohen, H., & Atias, S. (2002). Outcome of naltrexone maintenance following ultra rapid opiate detoxification versus intensive inpatient detoxification. AmJ Addict, 11(1), 52-56.

Robles, E., Stitzer, M. I., Strain, E. C., Bigelow, G. E., & Silverman, K. (2002). Voucher-based reinforcement of opiate abstinence during methadone detoxification. Drug Alcohol Depend, 65(2), 179-189.

Rosenthal, M. S. (1989). The therapeutic community: Exploring the boundaries. Br J Addict, 84, 141-150.

Senay, E. C. (1983). Substance abuse disorders in clinical practice. Littleton, MA: John Wright/PSG.

Spencer, L., & Gregory, M. (1989). Clonidine transdermal patches for use in outpatient opiate withdrawal. J Subst Abuse, 6, 113-117.

Substance Abuse and Mental Health Services Administration. (1995, November). Preliminary estimates from the Drug Abuse Warning Network (Advance Report No. 11). Washington, DC: Author.

Wilford, B. B. (1981). Drug abuse for the primary care physician. Chicago: American Medical Association.

Woody, G. E., McLellan, A. T., Luborsky, L., & O'Brien, C. P. (1985). Sociopathy and psychotherapy outcome. Arch Gen Psychiatry, 42, 1081-1086.

Brand Spanking New Detoxify

Brand Spanking New Detoxify

How To Safely Detoxify Your Body And Revitalize. Here's A Step-By-Step Plan To GetA Proper Mindset, Get Positive,And Most Of All... Find Your Special, Customized Detox Plan.

Get My Free Ebook

Post a comment